Luis Pérez Romasanta

Luis Pérez Romasanta
Hospital Universitario de Salamanca · Department of Radiation Oncology

MD, PhD

About

127
Publications
11,169
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
1,036
Citations
Additional affiliations
November 1992 - October 1994
Harvard Medical School
Position
  • Clinical-Research Fellow
July 2012 - present
Hospital Universitario de Salamanca
Position
  • Head of Department
November 2002 - November 2004
Massachusetts General Hospital
Position
  • Researcher
Education
September 2002 - October 2004
University of Santiago de Compostela
Field of study
  • Medicine (Doctoral Thesis)
September 1979 - July 1985
Universidad de Navarra
Field of study
  • Medicine

Publications

Publications (127)
Article
Full-text available
Background Stereotactic radiotherapy is the preferred treatment for managing patients with fewer than five brain metastases (BMs). However, some lesions recur after irradiation. The purpose of this study was to identify patients who are at a higher risk of failure, which can help in adjusting treatments and preventing recurrence. Methods In this r...
Preprint
Full-text available
Background. Stereotactic radiotherapy is the preferred treatment for managing patients with fewer than five brain metastases (BMs). However, some lesions recur after irradiation. The purpose of this study was to identify patients who are at a higher risk of failure, which can help in adjusting treatments and preventing recurrence. Methods. In this...
Article
Full-text available
Background The Response Assessment in Neuro-Oncology for Brain Metastases (RANO-BM) criteria are the gold standard for assessing brain metastases (BMs) treatment response. However, they are limited by their reliance on one dimension, despite the routine use of high-resolution T1-weighted MRI scans for BMs, which allows for 3D measurements. Our stud...
Article
Full-text available
Tumor growth is the result of the interplay of complex biological processes in huge numbers of individual cells living in changing environments. Effective simple mathematical laws have been shown to describe tumor growth in vitro, or simple animal models with bounded-growth dynamics accurately. However, results for the growth of human cancers in pa...
Article
Full-text available
Simple Summary Most Spanish specialists involved in the clinical management of spinal cord compression are familiar with the scoring systems for spine instability and spinal compression as well as with the NICE guideline recommendations. However, many do not apply them in routine practice. Scores on the scales used to evaluate spine instability in...
Article
Full-text available
Brain metastasis (BM) is one of the main complications of many cancers, and the most frequent malignancy of the central nervous system. Imaging studies of BMs are routinely used for diagnosis of disease, treatment planning and follow-up. Artificial Intelligence (AI) has great potential to provide automated tools to assist in the management of disea...
Article
Full-text available
Background Radiation necrosis (RN) is a frequent adverse event after fractionated stereotactic radiotherapy (FSRT) or single-session stereotactic radiosurgery (SRS) treatment of brain metastases (BMs). It is difficult to distinguish RN from progressive disease (PD) due to their similarities on the magnetic resonance images (MRIs). Previous theoreti...
Article
Full-text available
Purpose: Most monotherapies available against glioblastoma multiforme (GBM) target individual hallmarks of this aggressive brain tumor with minimal success. In this article, we propose a therapeutic strategy using coenzyme Q10 (CoQ10) as a pleiotropic factor that crosses the blood-brain barrier and accumulates in cell membranes acting as an antiox...
Conference Paper
Full-text available
Introduction/Background Routine follow-up for patients treated for gynecological malignancies aims to detect early recurrence, provide support and to evaluate treatment related morbidity and mortality. Evidence-based follow-up strategies are still lacking and the effectiveness of routine follow-up procedures in terms of survival and quality of life...
Preprint
Full-text available
Tumor growth is the result of the interplay of complex biological processes in a huge number of individual cells in a changing environment. Effective simple mathematical laws have been shown to describe tumor growth in vitro, or in animal models with bounded-growth dynamics accurately. However, results for human cancers in patients are scarce. The...
Article
Purpose/Objective(s) SBRT-SG 05 is a collaborative (SBRT-SG, GICOR and SEOR) prospective multicenter phase II trial testing SBRT and androgen deprivation therapy (ADT) in oligorecurrent prostate cancer patients. Materials/Methods Prostate cancer patients (hormone-sensitive or castration-resistant) in an oligorecurrent stage defined as less than 5...
Article
Full-text available
Low-grade gliomas (LGGs) are brain tumors characterized by their slow growth and infiltrative nature. Treatment options for these tumors are surgery, radiation therapy and chemotherapy. The optimal use of radiation therapy and chemotherapy is still under study. In this paper, we construct a mathematical model of LGG response to combinations of chem...
Article
Full-text available
Administering preoperative radiochemotherapy (RCT) in stage II-III tumors to locally advanced rectal carcinoma patients has proved to be effective in a high percentage of cases. Despite this, 20–30% of patients show no response or even disease progression. At present, preoperative response is assessed by a combination of imaging and tumor regressio...
Article
Full-text available
Brain metastases (BMs) are cancer cells that spread to the brain from primary tumors in other organs. Up to 35% of adult cancer patients develop BMs. The treatment of BM patients who have well-controlled extracranial disease and a small number of lesions consists of localized doses of radiation (stereotactic radio surgery (SRS)). Estimating prognos...
Article
Full-text available
Stereotactic body radiotherapy (SBRT) is an emerging ablative modality for hepatocellular carcinoma (HCC). Most patients with HCC have advanced disease at the time of diagnosis, and therefore, are not candidates for definitive-intent therapies such as resection or transplantation. For this reason, various alternative local and regional therapies ha...
Article
Background: MRI is assumed to be valid for distinguishing metastatic vertebral fractures (MVFs) from osteoporotic vertebral fractures (OVFs). This study assessed (1) concordance between the image-based diagnosis of MVF versus OVF and the reference (biopsy or follow-up of >6 months), (2) interobserver and intraobserver agreement on key imaging find...
Article
Purpose/objective: To investigate precision radiotherapy for metastatic spinal cord compression (MSCC) and compare it to conventional radiotherapy. Methods and materials: In a multi-center phase 2 study, 40 patients received 5Gyx5 of precision radiotherapy (38 volume modulated arc therapy, 2 intensity-modulated radiotherapy) for MSCC and were ev...
Article
Full-text available
Background: Patients with metastatic spinal cord compression (MSCC) and favorable survival prognoses can benefit from radiation doses greater than 30Gy in 10 fractions in terms of improved local progression-free survival (LPFS) and overall survival (OS). Methods/design: This prospective study mainly investigates LPFS after precision radiotherapy...
Article
Full-text available
External beam radiation therapy is a widespread treatment for prostate cancer. The ensuing patient follow-up is based on the evolution of the prostate-specific antigen (PSA). Serum levels of PSA decay due to the radiation-induced death of tumour cells and cancer recurrence usually manifest as a rising PSA. The current definition of biochemical rela...
Article
The original version of this article, published on 15 October 2018, unfortunately contained a mistake. The following correction has therefore been made in the original: The name of Mariano Amo-Salas and the affiliation of Ismael Herruzo were presented incorrectly.
Article
Objectives We wished to determine whether tumor morphology descriptors obtained from pretreatment magnetic resonance images and clinical variables could predict survival for glioblastoma patients. Methods A cohort of 404 glioblastoma patients (311 discoveries and 93 validations) was used in the study. Pretreatment volumetric postcontrast T1-weight...
Article
Objectives: To investigate how the modulation of the oxidative balance affects cytotoxic therapies in glioblastoma, in vitro. Material and methods: Human glioblastoma U251 and T98 cells and normal astrocytes C8D1A were loaded with coenzyme Q10 (CoQ). Mitochondrial superoxide ion (O2-) and H2O2 were measured by fluorescence microscopy. OXPHOS per...
Article
Full-text available
Bone marrow-mesenchymal stromal cells are precursors of adipocytes and osteoblasts and key regulators of hematopoiesis. Irradiation is widely used in conditioning regimens. Despite mesenchymal stromal cells are radio-resistant, the effects of low-dose irradiation on their behavior have not been extensively explored. Our aim was to evaluate the effe...
Article
Full-text available
Introduction: Glioblastoma is the most frequent and lethal malignant brain tumor in adults. Preoperative magnetic resonance imaging is routinely used for diagnosis and treatment planning. One of the gold standards in imaging are the post-contrast T1-weighted magnetic resonance images (MRIs) that are used to define the macroscopic part of the tumor....
Conference Paper
The potential of tumor's volumetric and texture measures obtained from pretreatment magnetic resonance imaging (MRI) sequences of glioblastoma (GBM) patients as predictors of clinical outcome has been controversial. Mathematical models of GBM growth have suggested a relation between tumor's geometry and its aggressiveness. Multicenter retrospective...
Article
Full-text available
Applied mathematics and nonlinear sciences have an enormous application potential in cancer. Mathematics can help in rising novel hypotheses to test, developing novel optimized treatment schedules and personalizing therapies. However, in spite of a large amount of global activity on the topic, this potential is yet to be proven in real-world applic...
Article
Background: The potential of a tumour's volumetric measures obtained from pretreatment MRI sequences of glioblastoma (GBM) patients as predictors of clinical outcome has been controversial. Mathematical models of GBM growth have suggested a relation between a tumour's geometry and its aggressiveness. Methods: A multicenter retrospective clinical...
Article
Objectives: The main objective of this retrospective work is the study of 3D heterogeneity measures of post-contrast preoperative magnetic resonance images (MRI) acquired with T1-weighted sequences of glioblastoma (GBM) patients as predictors of clinical outcome. Methods: 79 patients from three hospitals were included in the study. 16 3D textura...
Article
Grade II gliomas are slowly growing primary brain tumours that affect mostly young patients and become fatal after a variable time period. Current clinical handling includes surgery as first-line treatment. Cyto-toxic therapies (radiotherapy RT or chemotherapy QT) are used initially only for patients having a bad prognosis. Therapies are administer...
Article
To assess variability in the use of Tomita and modified Bauer scores in spine metastases. Clinical data and imaging from 90 patients with biopsy-proven spinal metastases, were provided to 83 specialists from 44 hospitals. Spinal levels involved and the Tomita and modified Bauer scores for each case were determined twice by each clinician, with a mi...
Article
Seven phase I-II studies fell within the inclusion criteria. Details on the radiotherapy technique, patient selection, fractionation scheme, exclusion criteria, treatment toxicity, quality-of-life, and tumor control were collected. The studies provide encouraging results of acute and late toxicity, with rare grade 3 events, that seem comparable to...
Article
Full-text available
Glioblastoma multiforme (GBM), the most frequent type of primary brain tumour, is a rapidly evolving and spatially heterogeneous high-grade astrocytoma that presents areas of necrosis, hypercellularity and microvascular hyperplasia. The aberrant vasculature leads to hypoxic areas and results in an increase in oxidative stress, selecting for more in...
Article
Full-text available
Low-grade gliomas (LGGs) are a group of primary brain tumours usually encountered in young patient populations. These tumours represent a difficult challenge because many patients survive a decade or more and may be at a higher risk for treatment-related complications. Specifically, radiation therapy is known to have a relevant effect on survival b...
Article
Functional imaging and its application to radiotherapy (RT) is a rapidly expanding field with new modalities and techniques constantly developing and evolving. As technologies improve, it will be important to pay attention to their implementation. This review describes the main achievements in the field of head and neck cancer (HNC) with particular...
Conference Paper
Glioblastoma multiforme (GBM) is the most frequent adult primary brain tumor, witl a media¡ sun ival of only 15 months following the standard of care. As other cance6. GBV cells have inc¡eased levels of ftee radicals, which togethe¡ with the hlpoúc microenvironment stabilize HIF I -o and promote the glycolltic switch vs. OXPHOS. initiate neovascula...
Article
Single-institution single-arm prospective study. Endpoint: To assess whether there are more than 5 % of men having grade 3 GU or any grade 3 GI acute toxicity during stereotactic body radiation therapy (SBRT) for prostate cancer using helical tomotherapy. Since May 2012, 17 prostate cancer patients were treated with helical tomotherapy. The exclusi...
Article
Purpose To prospectively study acute genitourinary (GU) and gastrointestinal (GI) toxicity during hypofractionated radiotherapy. Patients and materials One-hundred and seventy-one consecutive men with cT1-T3cN0cM0 prostate cancer were treated at 2.6 Gy/fraction to a total dose of 67.6 for low risk (EQD2 = 79 Gy) and 70.2 Gy for intermediate–high ri...